Minerva Neurosciences (NERV) Change in Acquisitions & Divestments (2015 - 2020)

Minerva Neurosciences (NERV) posted Change in Acquisitions & Divestments of $3.0 million for Q3 2020, down 33.33% on a QoQ basis from $4.5 million in Q2 2020, and down 91.63% year-over-year from $35.8 million in Q4 2019.

Minerva Neurosciences (NERV) Change in Acquisitions & Divestments (2015 - 2020) Analysis & Trends

Minerva Neurosciences' Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $3.0 million for Q3 2020.

  • Quarterly Change in Acquisitions & Divestments fell 91.63% year-over-year to $3.0 million in Q3 2020, while the trailing twelve-month figure through Dec 2020 was $28.4 million (down 62.22% YoY) and the FY2020 annual result came in at $28.4 million, down 62.22% from the prior year.
  • Change in Acquisitions & Divestments was $3.0 million for Q3 2020 at Minerva Neurosciences, down from $4.5 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $39.2 million in Q1 2018 and bottomed at $1.4 million in Q2 2016.
  • A 4-year average of $16.5 million and a median of $9.2 million in 2019 frame the typical range for Change in Acquisitions & Divestments.
  • Peak annual rise in Change in Acquisitions & Divestments reached 132.22% in 2020, while the deepest fall reached 91.63% in 2020.
  • Minerva Neurosciences' Change in Acquisitions & Divestments stood at $8.4 million in 2016, then tumbled by 36.72% to $5.3 million in 2018, then surged by 76.11% to $9.3 million in 2019, then tumbled by 67.86% to $3.0 million in 2020.
  • Business Quant data shows NERV's Change in Acquisitions & Divestments at $3.0 million in Q3 2020, $4.5 million in Q2 2020, and $20.9 million in Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,042.03 Bn 67,041.74 Bn -
2 Nanobiotix 1,911.83 Bn 1,911.77 Bn -
3 Akari Therapeutics 989.71 Bn 989.71 Bn -
4 BeOne Medicines 471.62 Bn 466.83 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.97 Bn 114.72 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.98 Bn 61.22 Bn 3.31 Bn
7 Belite Bio 62.68 Bn 62.68 Bn -
8 Argenx Se 55.75 Bn 50.57 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn
10 Minerva Neurosciences 183.94 Mn 183.94 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2020 3.00 Mn
Sep 30, 2020 3.00 Mn
Jun 30, 2020 4.50 Mn
Jun 30, 2020 4.50 Mn
Mar 31, 2020 20.90 Mn
Mar 31, 2020 20.90 Mn
Dec 31, 2019 9.33 Mn
Dec 31, 2019 9.33 Mn
Sep 30, 2019 35.85 Mn
Sep 30, 2019 35.85 Mn
Jun 30, 2019 21.00 Mn
Jun 30, 2019 21.00 Mn
Mar 31, 2019 9.00 Mn
Mar 31, 2019 9.00 Mn
Dec 31, 2018 5.30 Mn
Dec 31, 2018 5.30 Mn
Sep 30, 2018 29.50 Mn
Sep 30, 2018 29.50 Mn
Jun 30, 2018 36.10 Mn
Jun 30, 2018 36.10 Mn